Affimed to Present at the 2022 Jefferies Healthcare Conference
May 26 2022 - 06:30AM
Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a
clinical-stage immuno-oncology company committed to giving patients
back their innate ability to fight cancer, announced today that its
Chief Executive Officer, Dr. Adi Hoess, will present at the 2022
Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 1:00
p.m. Eastern Daylight Time / 19:00 Central European Time.
A live webcast of the presentation will be
accessible on Affimed’s website at
https://www.affimed.com/investors/webcasts-and-corporate-presentation/.
A replay of the call will be archived on Affimed’s website for 30
days after the call.
For more information on the conference or to
schedule a one-on-one meeting with Affimed’s management, please
contact Jefferies or Alex Fudukidis via email at
a.fudukidis@affimed.com or phone at +1 (917) 436-8102.
About Affimed N.V.Affimed
(Nasdaq: AFMD) is a clinical-stage immuno-oncology company
committed to giving patients back their innate ability to fight
cancer by actualizing the untapped potential of the innate immune
system. The Company’s proprietary ROCK® platform enables a
tumor-targeted approach to recognize and kill a range of
hematologic and solid tumors, enabling a broad pipeline of
wholly-owned and partnered single agent and combination therapy
programs. The ROCK® platform predictably generates customized
innate cell engager (ICE®) molecules, which use patients’ immune
cells to destroy tumor cells. This innovative approach enabled
Affimed to become the first company with a clinical-stage ICE®.
Headquartered in Heidelberg, Germany, with offices in New York, NY,
Affimed is led by an experienced team of biotechnology and
pharmaceutical leaders united by a bold vision to stop cancer from
ever derailing patients’ lives. For more about the Company’s
people, pipeline and partners, please visit: www.affimed.com.
Affimed Investor ContactAlexander
FudukidisDirector, Head of Investor RelationsE-Mail:
a.fudukidis@affimed.comTel.: +1 (917) 436-8102
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Feb 2024 to Mar 2024
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Mar 2023 to Mar 2024